Efficacy of immune checkpoint inhibitors differs in various status of carcinoma: a study based on 29 cohorts with 3255 participants
ConclusionsThis study indicated that the presence of viral infection was evidently associated with improved outcomes in cancer patients undergoing ICIs, particularly in cases of HBV/HCV and HPV infections.
Source: Cancer Immunology, Immunotherapy - Category: Cancer & Oncology Source Type: research
More News: Allergy & Immunology | Cancer | Cancer & Oncology | Carcinoma | Databases & Libraries | Gastric (Stomach) Cancer | Gastroenterology | Head and Neck Cancer | Hepatitis | Hepatitis B | Hepatitis C | Hepatocellular Carcinoma | HNSCC | Human Papillomavirus (HPV) | Immunotherapy | Liver Cancer | Nasopharyngeal Cancer | Skin Cancer | Squamous Cell Carcinoma | Study